Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - MERA PHARMACEUTICALS INC | mrpi_10q.htm |
| EX-31.1 - CERTIFICATION - MERA PHARMACEUTICALS INC | mrpi_311.htm |
| EX-31.2 - CERTIFICATION - MERA PHARMACEUTICALS INC | mrpi_312.htm |
| EX-32.1 - CERTIFICATION - MERA PHARMACEUTICALS INC | mrpi_321.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 UNITED STATES CODE SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Lawrence H. Wolfe, Chief Executive Officer of Mera Pharmaceuticals, certify that (1) Mera Pharmaceuticals, Inc.’s Form 10-Q for the quarter ended April 30, 2011 fully complies with the requirements of Section 3 (a) or 15 (d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Form 10-Q for the quarter ended April 30,, 2011 fairly presents, in all material respects, the financial condition and the results of operations of Mera Pharmaceuticals, Inc.
Date: July 25, 2012
/s/ Lawrence H. Wolfe
----------------------------------------
Lawrence H. Wolfe
Principal Financial and Accounting Officer